PubRank

Takeshi Miwa

Author PubWeight™ 27.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Smooth muscle alpha-actin deficiency in myofibroblasts leads to enhanced renal tissue fibrosis. J Biol Chem 2006 1.24
2 Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of Angiotensin-converting enzyme inhibitor. Circulation 2004 1.24
3 Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice. Hum Mol Genet 2006 1.09
4 High prevalence of irritable bowel syndrome in medical outpatients in Japan. J Clin Gastroenterol 2008 1.06
5 Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart. Cardiovasc Res 2002 1.06
6 Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: Beneficial effects of mineralocorticoid receptor blocker. Am J Physiol Regul Integr Comp Physiol 2006 1.05
7 The Polycomb-group gene Rae28 sustains Nkx2.5/Csx expression and is essential for cardiac morphogenesis. J Clin Invest 2002 1.01
8 Cytomegalovirus enterocolitis in an immunocompetent individual. J Clin Gastroenterol 2002 0.99
9 AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure. Hypertension 2004 0.98
10 Mice lacking connexin45 conditionally in cardiac myocytes display embryonic lethality similar to that of germline knockout mice without endocardial cushion defect. Cell Commun Adhes 2003 0.93
11 Cytokine expressions and H. pylori-associated gastric mucosal lesion. Keio J Med 2002 0.92
12 L-Carnitine prevents the development of ventricular fibrosis and heart failure with preserved ejection fraction in hypertensive heart disease. J Hypertens 2012 0.90
13 Ca2+ entry mode of Na+/Ca2+ exchanger as a new therapeutic target for heart failure with preserved ejection fraction. Eur Heart J 2011 0.88
14 Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation. Cardiovasc Res 2003 0.88
15 ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure. J Hypertens 2005 0.87
16 Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure. J Hypertens 2007 0.85
17 Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction. PLoS One 2013 0.85
18 Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure. J Hypertens 2009 0.84
19 Angiotensin II type 1 receptor blockade prevents diastolic heart failure through modulation of Ca(2+) regulatory proteins and extracellular matrix. J Hypertens 2003 0.83
20 CCAAT/Enhancer-binding protein delta contributes to myofibroblast transdifferentiation and renal disease progression. J Am Soc Nephrol 2004 0.82
21 Coronary vasospasm induced in transgenic mouse with increased phospholipase C-δ1 activity. Circulation 2012 0.81
22 Overexpression of Polycomb-group gene rae28 in cardiomyocytes does not complement abnormal cardiac morphogenesis in mice lacking rae28 but causes dilated cardiomyopathy. Lab Invest 2002 0.81
23 A novel heart failure mice model of hypertensive heart disease by angiotensin II infusion, nephrectomy, and salt loading. Am J Physiol Heart Circ Physiol 2013 0.81
24 Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats. Cardiovasc Res 2005 0.80
25 Temocapril prevents transition to diastolic heart failure in rats even if initiated after appearance of LV hypertrophy and diastolic dysfunction. Cardiovasc Res 2003 0.80
26 Beneficial effects of bisoprolol on the survival of hypertensive diastolic heart failure model rats. Eur J Heart Fail 2008 0.79
27 Roles of tumor necrosis factor-alpha-receptor type 1 and Fas in the Helicobacter pylori-induced apoptosis of gastric epithelial cells. J Gastroenterol Hepatol 2002 0.79
28 Human smooth muscle alpha-actin promoter drives Cre recombinase expression in the cranial suture in addition to smooth muscle cell. Biosci Biotechnol Biochem 2007 0.76
29 N-methylethanolamine attenuates cardiac fibrosis and improves diastolic function: inhibition of phospholipase D as a possible mechanism. Eur Heart J 2004 0.76
30 Angiotensin II type 1 and endothelin type A receptor antagonists modulate the extracellular matrix regulatory system differently in diastolic heart failure. J Hypertens 2003 0.76
31 For whom do physicians examine gastric emptying? The actual situation and prospects for gastric emptying measurement. J Gastroenterol 2002 0.75
32 [Morphological and functional changes in the digestive mucosa due to aging]. Nihon Rinsho 2002 0.75
33 [Stomach cancer]. Nihon Naika Gakkai Zasshi 2002 0.75
34 [cag PAI and gastric carcinogenesis-association with p53 gene mutation]. Nihon Rinsho 2003 0.75
35 [A case of multiple excavated early duodenal carcinoma]. Nihon Shokakibyo Gakkai Zasshi 2002 0.75